Clinical Trials | November 29, 2021
AMPATH launches its pathology laboratory in Mumbai
The company has has 10 existing labs in India
The company has has 10 existing labs in India
The funds will be used to scale up existing operations and launch new products
It’s a two-dose vaccine administered 28 days apart
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Subscribe To Our Newsletter & Stay Updated
